Bladder Cancer

1 stories about Bladder Cancer
default image

Cancer Treatment Company Negotiating $20-25 Million Capital Injection

29.10.17|Lilach Baumer
The potential investors condition the investment on delisting BioCanCell from the Tel Aviv Stock Exchange